Investors flee COVID pill drugmaker on news of birth defect risk

Published

3 years ago

13 April 2022

Terry Power

Shionogi COVID pill: Investors flee drugmaker on news of birth defect risk | Fortune

You need to enable JavaScript to view this site.

Related Topics:Birth COVID defect drugmaker flee investors News Pill risk